T-cell immunotherapy with a chimeric receptor against CD38 is effective in eliminating myeloma cells

K. Mihara; J. Bhattacharyya; A. Kitanaka; K. Yanagihara; T. Kubo; Y. Takei; H. Asaoku; Y. Takihara; A. Kimura

doi:10.1038/leu.2011.205

T-cell immunotherapy with a chimeric receptor against CD38 is effective in eliminating myeloma cells

K. Mihara
, J. Bhattacharyya
, A. Kitanaka
, K. Yanagihara
, T. Kubo
, Y. Takei
, H. Asaoku
, Y. Takihara
, A. Kimura

Research output: Contribution to journal › Letter › peer-review

Original language	English
Pages (from-to)	365-367
Number of pages	3
Journal	Leukemia
Volume	26
Issue number	2
DOIs	https://doi.org/10.1038/leu.2011.205
Publication status	Published - 02-2012
Externally published	Yes

All Science Journal Classification (ASJC) codes

Hematology
Oncology
Cancer Research

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1038/leu.2011.205

Cite this

@article{2dda5139d82a400385bbebbea4dc01bb,

title = "T-cell immunotherapy with a chimeric receptor against CD38 is effective in eliminating myeloma cells",

author = "K. Mihara and J. Bhattacharyya and A. Kitanaka and K. Yanagihara and T. Kubo and Y. Takei and H. Asaoku and Y. Takihara and A. Kimura",

note = "Funding Information: leukaemia: a study of the United Kingdom Medical Research Council Adult Leukaemia Working Party. Br J Haematol 2009; 146: 54–63.",

year = "2012",

month = feb,

doi = "10.1038/leu.2011.205",

language = "English",

volume = "26",

pages = "365--367",

journal = "Leukemia",

issn = "0887-6924",

publisher = "Springer Nature",

number = "2",

}

TY - JOUR

T1 - T-cell immunotherapy with a chimeric receptor against CD38 is effective in eliminating myeloma cells

AU - Mihara, K.

AU - Bhattacharyya, J.

AU - Kitanaka, A.

AU - Yanagihara, K.

AU - Kubo, T.

AU - Takei, Y.

AU - Asaoku, H.

AU - Takihara, Y.

AU - Kimura, A.

N1 - Funding Information: leukaemia: a study of the United Kingdom Medical Research Council Adult Leukaemia Working Party. Br J Haematol 2009; 146: 54–63.

PY - 2012/2

Y1 - 2012/2

UR - https://www.scopus.com/pages/publications/84856760798

UR - https://www.scopus.com/pages/publications/84856760798#tab=citedBy

U2 - 10.1038/leu.2011.205

DO - 10.1038/leu.2011.205

M3 - Letter

C2 - 21836610

AN - SCOPUS:84856760798

SN - 0887-6924

VL - 26

SP - 365

EP - 367

JO - Leukemia

JF - Leukemia

IS - 2

ER -

T-cell immunotherapy with a chimeric receptor against CD38 is effective in eliminating myeloma cells

All Science Journal Classification (ASJC) codes

UN SDGs

Access to Document

Other files and links

Cite this